Table 3.
Postoperative Recovery Situation
| Variables | Diprospan group (n = 48) | Control group (n = 48) | Mean difference or RR (estimate 95% CI) | P value |
|---|---|---|---|---|
| PONV | ||||
| 2 h | 0 (0–0) | 0 (0–0) | .808a | |
| 4 h | 0 (0–1) | 0 (0–1) | .941a | |
| 8 h | 0 (0–1) | 0 (0–1) | .831a | |
| 24 h | 0 (0–0.5) | 0 (0–1) | .821a | |
| 48 h | 0 (0–0) | 0 (0–0) | .603a | |
| Summary, n (%) | 25 (52.1) | 23 (47.9) | 0.92 (0.62–1.3)b | |
| RSS | ||||
| 2 h | 3 (3–3) | 3 (3–3) | .696a | |
| 4 h | 3 (2–3) | 3 (2–3) | .833a | |
| 8 h | 2 (2–3) | 2 (2–3) | .678a | |
| 24 h | 2 (2–2) | 2 (2–2) | 1.000a | |
| 48 h | 2 (2–2) | 2 (2–2) | .696a | |
| Length of stay | 13 (11–14) | 14 (12–16) | .240a | |
Values presented as median and interquartile range (25%–75%).
Diprospan group: ropivacaine plus Diprospan group; control group: ropivacaine alone group.
Abbreviations: CI, confidence interval; PONV, postoperative nausea and vomiting; RR, risk ratio; RSS, Ramsay Sedation Scale.
This value is RR.
Wilcoxon rank-sum test.